echoloc
Get started
echoloc/ Companies/ Kymera Therapeutics
Company profile

Kymera Therapeutics Tech Stack

Clinical-stage oral protein degrader developer for immunological diseases

Biotechnology Research Watertown, MA 51–200 employees Founded 2016 Public Company
kymeratx.com LinkedIn

Kymera Therapeutics develops oral small molecule degraders using targeted protein degradation, with immunology as its clinical focus. Hiring skews senior and director-level across clinical, research and regulatory, and projects around global commercial strategy for KT-621 and oral solid dose readiness point to a shift from clinical development toward commercialization. The stack pairs Veeva Vault, CDISC and SAS for regulated trial data with OpenAI, Anthropic and Azure OpenAI.

Tech Stack 31 technologies

Core StackSAS OpenAI Anthropic Python MATLAB AWS Terraform CloudFormation Intune Greenhouse Blackboard Collaborate CDISC LC-MS Veeva Vault Azure OpenAI Veeva HPLC GCP Azure Entra SD-WAN MaxQuant Veeva RIM Azure AD Connect Exchange Online Spotfire Benchling LinkedIn Recruiter
AdoptingPython

What Kymera Therapeutics Is BuildingChallenges and projects from their job posts

◆Challenges

  • Improving clinical data management processes and timelines
  • Accelerating site activation and patient enrollment
  • Commercial-scale technology transfer
  • Cross-functional regulatory coordination
  • Maximizing patient access
  • Managing clinical vendor relationships

▲Active Projects

  • Global commercial strategy for KT-621
  • Commercial readiness for oral solid dosage forms
  • CMC regulatory strategy and submissions
  • Implementing Veeva Vault document control and eTMF
  • Global clinical trial execution and site monitoring
  • Answer engine optimization strategy

Hiring Activity

Decelerating35 roles · 6 in 30d

Department

Healthcare
8
Research
7
Ops
5
Data
3
Engineering
3
Legal
2
Operations
2
Marketing
1

Seniority

Senior
21
Director
10
VP
3

Notable leadership hires: IT Director, Director, Outcomes, Value & Access, Medical Director

Companies like Kymera Therapeutics

100+ Biotechnology Research companies running SAS and Python

See the full list

About Kymera Therapeutics

Kymera Therapeutics is a public, clinical-stage biotechnology company headquartered in Watertown, MA, founded in 2016. It applies targeted protein degradation to disease targets that conventional drugs struggle to reach, prioritizing oral small molecule therapies for immunological conditions. The company employs 51–200 people, runs research and clinical operations, and is currently recruiting in the United Kingdom. Its operations span discovery science, clinical trial execution, regulatory affairs and early commercial planning.

HeadquartersWatertown, MA
Company Size51–200 employees
Founded2016
Hiring MarketsUnited Kingdom

Frequently Asked Questions

What tech stack does Kymera Therapeutics use?

Kymera uses Veeva Vault, Veeva RIM, CDISC, SAS, Spotfire and Benchling for clinical and R&D data, Python and MATLAB for analysis, AWS, GCP and Azure with Terraform for cloud, plus OpenAI, Anthropic and Azure OpenAI.

What is Kymera Therapeutics working on?

Current initiatives include global commercial strategy for KT-621, CMC regulatory strategy and submissions, implementing Veeva Vault and eTMF, global clinical trial execution, and commercial readiness for oral solid dosage forms.

Where is Kymera Therapeutics headquartered?

Kymera Therapeutics is headquartered in Watertown, MA, United States, and has 51–200 employees. It is also hiring in the United Kingdom.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size

K
Kodiak Sciences
Biotechnology Research
I
Immunome, Inc.
Biotechnology Research
S
Structure Therapeutics
Biotechnology Research
A
Artos AI
Biotechnology Research

How this profile is built

Kymera Therapeutics's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.